{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:00:05Z","timestamp":1780725605856,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-04116"],"award-info":[{"award-number":["RGPIN-2017-04116"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031571","name":"Libin Cardiovascular Institute, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 142467"],"award-info":[{"award-number":["MOP 142467"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.metabol.2025.156410","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:06:46Z","timestamp":1759360006000},"page":"156410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Administration of the KCa channel activator SKA-31 improves long-term endothelial function, blood pressure regulation and cardiac performance in rats with type 2 diabetes"],"prefix":"10.1016","volume":"174","author":[{"given":"Ramesh C.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Khaddaj Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cini M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell D.","family":"Belke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyoeb","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156410_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2025.156410_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2025.156410_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease \u2014 a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.metabol.2025.156410_bb0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and microvascular endothelial dysfunction in diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.metabol.2025.156410_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2025.156410_bb0030","doi-asserted-by":"crossref","first-page":"H985","DOI":"10.1152\/ajpheart.00292.2006","article-title":"Endothelial dysfunction: a multifaceted disorder","volume":"291","author":"F\u00e9l\u00e9tou","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0035","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease. Pathophysiology, clinical consequences and medical therapy: part I","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2025.156410_bb0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease. Pathophysiology, clinical consequences and medical therapy: part II","volume":"108","author":"L\u00fcscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2025.156410_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/cvr\/cvn354","article-title":"Does reversal of oxidative stress and inflammation provide vascular protection?","volume":"81","author":"Koh","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2025.156410_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1160\/TH12-05-0337","article-title":"Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation","volume":"108","author":"Antonopoulos","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.metabol.2025.156410_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/252158","article-title":"Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art","volume":"2013","author":"Radenkovic","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2025.156410_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.805149","article-title":"Endothelial ion channels and cell-cell communication in the microcirculation","volume":"13","author":"Jackson","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0065","doi-asserted-by":"crossref","first-page":"C458","DOI":"10.1152\/ajpcell.00036.2007","article-title":"Small- and intermediate-conductance Ca2+-activated K+ channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells","volume":"293","author":"Sheng","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1096\/fj.08-120451","article-title":"Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar dilation","volume":"23","author":"Sheng","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2025.156410_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.yjmcc.2014.04.013","article-title":"A pharmacologic activator of endothelial KCa channels enhances coronary flow in the hearts of type 2 diabetic rats","volume":"72","author":"Mishra","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FJC.0000000000000252","article-title":"Inhibition of myogenic tone in rat cremaster and cerebral arteries by SKA-31, an activator of endothelial KCa2.3 and KCa3.1 channels","volume":"66","author":"Mishra","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2018.05.006","article-title":"SKA-31, an activator of endothelial Ca2+-activated K+ channels evokes robust vasodilation in rat mesenteric arteries","volume":"831","author":"Khaddaj Mallat","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.770450","article-title":"Calcium-dependent ion channels and the regulation of arteriolar myogenic tone","volume":"12","author":"Jackson","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1152\/physrev.00035.2022","article-title":"The conducted vasomotor response and the principles of electrical communication in resistance arteries","volume":"104","author":"Mironova","year":"2024","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2025.156410_bb0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.RES.0000238377.08219.0c","article-title":"Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel","volume":"99","author":"Si","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2025.156410_bb0105","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.108.846634","article-title":"Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension","volume":"119","author":"Br\u00e4hler","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2025.156410_bb0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1476-5381.2009.00052.x","article-title":"Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?","volume":"156","author":"F\u00e9l\u00e9tou","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/14728222.2010.500616","article-title":"Calcium-activated potassium channels \u2014 a therapeutic target for modulating nitric oxide in cardiovascular disease?","volume":"14","author":"Dalsgaard","year":"2010","journal-title":"Exp Opin Ther Targ"},{"key":"10.1016\/j.metabol.2025.156410_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/FJC.0b013e318279ba20","article-title":"Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets","volume":"61","author":"Wulff","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.apha.2016.04.002","article-title":"Endothelial small- and intermediate-conductance K channels and endothelium-dependent hyperpolarization as drug targets in cardiovascular disease","volume":"77","author":"K\u00f6hler","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mol.108.051425","article-title":"Naphthol[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure","volume":"75","author":"Sankaranarayanan","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/19336950.2018.1454814","article-title":"Pharmacologic targeting of endothelial Ca2+-activated K+ channels: a strategy to improve cardiovascular function","volume":"12","author":"Mathew John","year":"2018","journal-title":"Channels"},{"key":"10.1016\/j.metabol.2025.156410_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154390","article-title":"KCa channel activation normalizes endothelial function in type 2 diabetic resistance arteries by improving intracellular Ca2+ mobilization","volume":"114","author":"Mishra","year":"2021","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2025.156410_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156001","article-title":"Targeting endothelial KCa channels in vivo restores arterial and endothelial function in type 2 diabetic rats","volume":"160","author":"Mishra","year":"2024","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2025.156410_bb0150","article-title":"SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging","volume":"151","author":"Mathew John","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2025.156410_bb0155","doi-asserted-by":"crossref","first-page":"19729","DOI":"10.1074\/jbc.M005711200","article-title":"A catalytically inactive mutant of type I cGMP-dependent protein kinase prevents enhancement of large conductance, calcium-sensitive K+ channels by sodium nitroprusside and cGMP","volume":"276","author":"Swayze","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156410_bb0160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cellimm.2011.08.017","article-title":"Immunomodulatory activity of polyphenols derived from Cassia auriculata flowers in aged rats","volume":"271","author":"John","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.metabol.2025.156410_bb0165","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jacc.2013.05.041","article-title":"Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice","volume":"62","author":"Seibert","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem J"},{"key":"10.1016\/j.metabol.2025.156410_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/jsre.2000.5862","article-title":"Regulation of intestinal blood flow","volume":"93","author":"Matheson","year":"2000","journal-title":"J Surg Res"},{"key":"10.1016\/j.metabol.2025.156410_bb0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156410_bb0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156410_bb0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2025.156410_bb0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156410_bb0200","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/jcm9072090","article-title":"Endothelial dysfunction: a contributor to adverse cardiovascular remodeling and heart failure development in Type 2 Diabetes beyond accelerated atherogenesis","volume":"9","author":"Gamrat","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2025.156410_bb0205","doi-asserted-by":"crossref","first-page":"H2392","DOI":"10.1152\/ajpheart.00403.2003","article-title":"Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus","volume":"285","author":"Beckman","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2003.08.051","article-title":"Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function","volume":"43","author":"Kinlay","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomized controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"Br Med J"},{"key":"10.1016\/j.metabol.2025.156410_bb0220","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.2174\/0929867329666220729154615","article-title":"Repurposing metformin for vascular disease","volume":"30","author":"Triggle","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.metabol.2025.156410_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pharmtox-010919-023420","article-title":"Pharmacology of small- and intermediate-conductance calcium-activated potassium channels","volume":"60","author":"Brown","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.metabol.2025.156410_bb0230","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.HYP.37.2.433","article-title":"Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats","volume":"37","author":"Cheng","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2025.156410_bb0235","series-title":"Animal models of diabetes","first-page":"119","article-title":"The Goto-Kakizaki rat","author":"Stenson","year":"2007"},{"key":"10.1016\/j.metabol.2025.156410_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-009-0178-2","article-title":"Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta","volume":"332","author":"Kazuyama","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2025.156410_bb0245","first-page":"R149","article-title":"Endothelium-dependent impairments to cerebral vascular reactivity with type 2 diabetes mellitus in the Goto-Kakizaki rat","volume":"317","author":"Halvorson","year":"2019","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"10.1016\/j.metabol.2025.156410_bb0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00395-004-0440-4","article-title":"Cardiac dysfunction in the Goto-Kakizaki rat","volume":"99","author":"El-Omar","year":"2004","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0255","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: epidemiology, biological mechansims, treatment recommendations and future research","volume":"6","author":"Leon","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.metabol.2025.156410_bb0260","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1476-5381.2010.00803.x","article-title":"Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles","volume":"160","author":"Dalsgaard","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0265","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1124\/jpet.111.179242","article-title":"Opening of small and intermediate calcium-activated potassium channels induces relaxation mainly mediated by nitric-oxide release in large arteries and endothelium-derived hyperpolarizing factor in small arteries from rat","volume":"339","author":"Stankevicius","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2025.156410_bb0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1748-1716.2010.02240.x","article-title":"Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+-activated K+ channels","volume":"203","author":"Hasenau","year":"2011","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.metabol.2025.156410_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1476-5381.2011.01546.x","article-title":"Pharmacological activation of KCa3.1\/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs","volume":"165","author":"Damkjaer","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0280","doi-asserted-by":"crossref","first-page":"H484","DOI":"10.1152\/ajpheart.00642.2012","article-title":"Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+\/calmodulin-dependent protein kinase kinase\/Akt\/p300 cascade","volume":"305","author":"Takai","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2005.08.030","article-title":"Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation","volume":"20","author":"Cheong","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2025.156410_bb0290","doi-asserted-by":"crossref","first-page":"C803","DOI":"10.1152\/ajpcell.00457.2005","article-title":"Transcriptional and posttranslational regulation of endothelial nitric oxide synthase expression","volume":"291","author":"Searles","year":"2006","journal-title":"Am J Phys Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156410_bb0295","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/HYPERTENSIONAHA.124.24537","article-title":"Impact of IKCa channel on CD34+ cells in angiotensin II-induced arteriole remodeling of hypertensive mice","volume":"82","author":"Tian","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2025.156410_bb0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.114.093286","article-title":"New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1","volume":"86","author":"Coleman","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0305","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/mol.117.109421","article-title":"Structural determinants for the selectivity of the positive KCa3.1 gating modulator 5-methylnaphtho[2,1-d]oxazol-2-amine (SKA-121)","volume":"92","author":"Brown","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0310","doi-asserted-by":"crossref","first-page":"1151244","DOI":"10.3389\/fphar.2023.1151244","article-title":"Endothelial KCa channels: novel targets to reduce atherosclerosis-driven vascular dysfunction","volume":"14","author":"Vera","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2025.156410_bb0315","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABA(A) receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2025.156410_bb0320","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.metabol.2025.156410_bb0325","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156410_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","article-title":"Statins and the endothelium","volume":"46","author":"Ii","year":"2007","journal-title":"Vasc Pharmacol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:05:06Z","timestamp":1780722306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"alternative-id":["S0026049525002793"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156410","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of the KCa channel activator SKA-31 improves long-term endothelial function, blood pressure regulation and cardiac performance in rats with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156410"}}